VildagliptinA Review of its Use in Type 2 Diabetes Mellitus

被引：0
作者：
Gillian M. Keating
机构：
[1] Adis,
[2] a Wolters Kluwer Business,undefined
来源：
Drugs | 2010年 / 70卷
关键词：
Metformin; Rosiglitazone; Pioglitazone; Acarbose; Sitagliptin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Vildagliptin (Galvus®, Jalra®, Xiliarx®) is an orally administered dipeptidyl peptidase-4 (DPP-4) inhibitor. In patients with type 2 diabetes mellitus, vildagliptin 50mg twice daily is indicated for use in combination with metformin or a thiazolidinedione, and vildagliptin 50mg once daily is indicated for use in combination with a sulfonylurea. A fixed-dose combination of vildagliptin/metformin (Eucreas®, Icandra®, Zomarist®) is also available. This article reviews the clinical efficacy and tolerability of vildagliptin in patients with type 2 diabetes, as well as summarizing its pharmacological properties.
引用
收藏
页码：2089 / 2112
页数：23
相关论文
共 250 条
  • [1] Neumiller JJ(2010)Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus Pharmacotherapy 30 463-84
  • [2] Wood L(2009)Vildagliptin in clinical practice: a review of literature Expert Opin Pharmacother 10 2745-57
  • [3] Campbell RK(2009)Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care 32 193-203
  • [4] Banerjee M(2009)Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use Am J Med 122 S37-50
  • [5] Younis N(2009)DPP-4 inhibitors in clinical practice Postgrad Med 121 70-100
  • [6] Soran H(2009)The scientific evidence: vildagliptin and the benefits of islet enhancement Diabetes Obes Metab 11 9-17
  • [7] Nathan DM(2008)The islet enhancer vildagliptin: mechanisms of improved glucose metabolism Int J Clin Pract 62 8-14
  • [8] Buse JB(2008)Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited Diabetes Obes Metab 10 1057-61
  • [9] Davidson MB(2007)Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT J Clin Pharmacol 47 633-41
  • [10] Kendall DM(2009)Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus Diabetes Res Clin Pract 83 233-40
12345678910